Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: A rationale for increasing drug exposure in castration-resistant prostate cancer

Article

Abstract: Purpose: Treatment with abiraterone (abi) acetate prolongs survival in castration-resistant prostate

Palabras claves:

Autores:

Chang K.H., Evaul K., Li R., Liu J., Richard J. Auchus, Sharifi N., Sharma K.K., Yoshimoto J.A.

Fuentes:

scopus